PURE BIOSCIENCE, INC. Filed by OKUNO DALE

Similar documents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934

Inventergy Global, Inc (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

LEGACY RESERVES LP Filed by BROTHERS PRODUCTION COMPANY, INC.

LEGACY RESERVES LP Filed by MORIAH PROPERTIES, LTD.

EATON CORP PLC Filed by WELLINGTON MANAGEMENT CO LLP

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. Support.com, Inc. Form: SC 13G/A. Date Filed:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

ShotSpotter, Inc. (Name of Issuer)

Common Stock, par value $0.01 per share (Title of Class of Securities)

OAKTREE CAPITAL GROUP, LLC Filed by JMB CAPITAL PARTNERS MASTER FUND L.P.

KINGSTONE COMPANIES, INC.

SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)

UNITED THERAPEUTICS CORP Filed by SHUMWAY CAPITAL PARTNERS LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

AON PLC Filed by CAPITAL RESEARCH & MANAGEMENT CO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

PRINCIPAL FINANCIAL GROUP INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

GOPHER PROTOCOL INC. Filed by FLEMING STEPHEN M.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. REVOLUTION LIGHTING TECHNOLOGIES (Name of Issuer)

Spark Therapeutics, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Algodon Wines & Luxury Development Group, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

Main Street Capital Corp.

ZYNGA INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (RULE 13d - 102)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934*

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G T100 (CUSIP Number)

THERAVANCE INC Filed by BAUPOST GROUP LLC/MA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Signet Jewelers (Name of Issuer)

Realogy Holdings Corp.

united StateS SeCuritieS and exchange COMMiSSiOn Washington, D.C SCHeDuLe 13g

ACCESS INTEGRATED TECHNOLOGIES INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Ecology & Environment, Inc.

GROUPON, INC. Filed by KEYWELL BRADLEY A

MEDICAL TRANSCRIPTION BILLING, CORP Filed by OMNI MEDICAL BILLING SERVICES, LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

ST JOE CO Filed by THIRD AVENUE MANAGEMENT LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment 2)*

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A Amendment No. 3. Under the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (RULE 13d - 102)

COMCAST CORP Filed by MICROSOFT CORP

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Limbach Holdings, Inc (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Rosehill Resources Inc. (Name of Issuer)

CENTERPOINT ENERGY INC Filed by VANGUARD GROUP INC

American Midstream Partners, LP (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.

GLOBUS MEDICAL INC Filed by PAUL DAVID C

VERISIGN INC/CA Filed by LONE PINE CAPITAL LLC

SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934

WASTE MANAGEMENT INC Filed by VANGUARD GROUP INC

SECURITIES & EXCHANGE COMMISSION EDGAR FILING CEL SCI CORP. Form: SC 13G/A. Date Filed:

SUNOPTA INC. Filed by GRUBER & MCBAINE CAPITAL MANAGEMENT LLC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

Everi Holdings Inc. (Name of Issuer)

LEAR CORP Filed by MERRILL LYNCH PIERCE FENNER & SMITH INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. KLR Energy Acquisition Corp.

NELNET INC Filed by CEDAR HILL CAPITAL PARTNERS, LLC

BARRETT BUSINESS SERVICES, INC. (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number)

ROCKWELL COLLINS INC Filed by VANGUARD GROUP INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

Floor & Décor Holdings, Inc. (Name of Issuer)

XILINX INC Filed by VANGUARD GROUP INC

SECURITIES AND EXCHANGE COMMISSION. Washington, D.C Schedule 13G. Under the Securities Exchange Act of (Amendment No.

Section 1: SC 13G/A (SC 13G/A)

BRIDGEPOINT EDUCATION, INC. (Name of Issuer)

Silvercrest Asset Management Group Inc. (Name of Issuer)

Taubman Centers, Inc. (Name of Issuer)

KAYNE ANDERSON MIDSTREAM ENERGY FUND, INC. (Name of Issuer)

3M CO Filed by BLACKROCK INC.

CASTLE BRANDS INC Filed by CAMULOS CAPITAL LP

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

NEVADA GOLD & CASINOS INC Filed by HABERKORN STEPHEN J

<SEQUENCE>1 <FILENAME>cpst_sc13g.txt. SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G

American Midstream Partners, LP (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, DC SCHEDULE 13G (Rule 13d-102)

SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G/A

Recro Pharma, Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (Rule 13d-102)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

FISERV INC Filed by BLACKROCK INC.

MOODYS CORP /DE/ Filed by CHILDRENS INVESTMENT FUND MANAGEMENT (UK) LLP

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. HCI Group, Inc. Form: SC 13G/A. Date Filed:

Limbach Holdings, Inc. (Name of Issuer)

HASBRO INC Filed by CAPITAL GROUP COMPANIES INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

NICE SYSTEMS LTD Filed by PSAGOT INVESTMENT HOUSE LTD.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

Alliqua BioMedical, Inc.

Securities and Exchange Commission. Washington, D.C Schedule 13G. Under the Securities Exchange Act of (Amendment No.

Propetro Holding Corp. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (Amendment No. ) Under the Securities Exchange Act of 1934

Canada Goose Holdings Inc. (Name of Issuer)

Transcription:

PURE BIOSCIENCE, INC. Filed by OKUNO DALE FORM SC 13G (Statement of Ownership) Filed 05/22/14 Address 1725 GILLESPIE WAY EL CAJON, CA, 92020 Telephone 619-596-8600 CIK 0001006028 Symbol PURE SIC Code 2890 - Miscellaneous Chemical Products Industry Household Products Sector Consumer Non-Cyclicals Fiscal Year 07/31 http://www.edgar-online.com Copyright 2019, EDGAR Online, a division of Donnelley Financial Solutions. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, a division of Donnelley Financial Solutions, Terms of Use.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 0)* PURE BIOSCIENCE, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 74621T209 (CUSIP Number) Dale Okuno 35 North Arroyo Parkway, Suite 1, Pasadena, CA 91103 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) February 4, 2014 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 ( Act ) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 74621T209 13G Page 2 of 5 Pages 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Dale Okuno 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION United States 5. SOLE VOTING POWER NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 1,485,714 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 1,485,714 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON Dale Okuno 1,485,714 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 12. TYPE OF REPORTING PERSON (see instructions) IN

CUSIP No. 74621T209 13G Page 3 of 5 Pages Item 1. (a) (b) Name of Issuer PURE BIOSCIENCE, INC. Address of Issuer s Principal Executive Offices 1725 Gillespie Way El Cajon, California 92020 Item 2. (a) (b) (c) (d) (e) Name of Person Filing Dale Okuno Address of the Principal Office or, if none, residence 35 North Arroyo Parkway, Suite 1, Pasadena, CA 91103 Citizenship United States Title of Class of Securities Common Stock CUSIP Number 74621T209 Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) (b) (c) (d) (e) (f) (g) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) (j) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); Group, in accordance with 240.13d-1(b)(1)(ii)(J).

CUSIP No. 74621T209 13G Page 4 of 5 Pages Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 1,485,714 (b) Percent of class: 5.47061% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 1,485,714 (ii) Shared power to vote or to direct the vote 0 (iii) Sole power to dispose or to direct the disposition of 1,485,714 (iv) Shared power to dispose or to direct the disposition of 0 Instruction. For computations regarding securities which represent a right to acquire an underlying security see 240.13d-3(d)(1). Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Item 8. Identification and Classification of Members of the Group. Item 9. Notice of Dissolution of Group. Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

CUSIP No. 74621T209 13G Page 5 of 5 Pages After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. 05/22/2014 Date /s/ Dale Okuno Signature Dale Okuno Name/Title